连续后路腰丛神经阻滞对比罗哌卡因或脂质体布比卡因关节周围注射用于全髋关节置换术:三臂随机临床试验
该三臂随机临床试验比较了连续后路腰丛阻滞(PNB)、罗哌卡因关节周围注射(PAI-R)和脂质体布比卡因关节周围注射(PAI-L)在全髋关节置换术后的镇痛效果。主要终点为术后第1天晨间最大疼痛评分,三组间无显著差异。二次分析提示PNB或PAI-L的术后镇痛优于PAI-R。
要点
- 术后第1天晨间最大疼痛评分三组中位数分别为3.0、4.0、3.0,两两比较均无显著差异。
- 术后第1天最大疼痛评分PAI-L组低于PAI-R组(中位数4.0对5.5,p=0.006)。
- 术后第2天最大疼痛评分PNB组和PAI-L组均低于PAI-R组(p=0.014和p=0.016)。
核心结论
- 本随机临床试验发现,与PAI-R相比,接受PNB的患者镇痛有适度改善,但与PAI-L相比无差异。
- 二次分析提示,PNB或PAI-L的术后镇痛优于PAI-R。
- 对于初次全髋关节置换术,包含PNB或PAI-L的多模式镇痛方案可提供限制阿片类药物用量的镇痛。
研究设计与样本
- 研究者发起、独立资助的三臂随机临床试验,在单一高手术量机构进行。
- 比较择期单侧初次全髋关节置换术的术后镇痛干预:PNB组、PAI-R组(罗哌卡因、酮咯酸和肾上腺素)和PAI-L组(脂质体布比卡因、酮咯酸和肾上腺素),采用计算机化随机分组。
- 主要终点为术后第1天晨间(06:00至12:00)最大疼痛,采用0至10分递增数字评定量表(NRS)。
- 样本量150例可提供80%把握度检测2.0个NRS单位的差异。
- 共纳入159例患者(PNB组51例、PAI-R组54例、PAI-L组54例)。
主要发现
- 术后第1天晨间主要终点中位数分别为3.0、4.0、3.0,所有两两比较p>0.033,无显著差异。
- 阿片类药物消耗量低,且在任何时间区间各组间均无差异。
- 术后第1天最大疼痛中位数分别为5.0、5.5、4.0,PAI-L组低于PAI-R组(p=0.006)。
- 术后第2天最大疼痛中位数分别为3.5、5.0、3.5,PNB组(p=0.014)和PAI-L组(p=0.016)均低于PAI-R组。
- PAI-L组与PNB组在任何结局上均无显著差异,包括术后阿片类药物使用(含补救性静脉阿片类药物)、住院时间和医院不良事件,以及3个月随访数据(含任何并发症)。
关键数值与推荐
- 主要终点采用0至10分递增数字评定量表(NRS)评估术后第1天晨间(06:00至12:00)最大疼痛。
- 两两比较采用秩和检验,p值<0.017表示显著(Bonferroni校正)。
- 样本量150例提供80%把握度检测2.0个NRS单位的差异。
临床怎么用
- 对于初次全髋关节置换术,包含PNB或PAI-L的多模式镇痛方案可提供限制阿片类药物用量的镇痛。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Debate surrounds the issue of whether peripheral nerve blockade or periarticular infiltration (PAI) should be employed within a contemporary, comprehensive multimodal analgesia pathway for total hip arthroplasty. We hypothesized that patients treated with a continuous posterior lumbar plexus block (PNB) would report less pain and consume less opioid medication than those treated with PAI. METHODS: This investigator-initiated, independently funded, 3-arm randomized clinical trial (RCT) performed at a single high-volume institution compared postoperative analgesia interventions for elective, unilateral primary total hip arthroplasty: (1) PNB; (2) PAI with ropivacaine, ketorolac, and epinephrine (PAI-R); and (3) PAI with liposomal bupivacaine, ketorolac, and epinephrine (PAI-L) using computerized randomization. The primary outcome was maximum pain during the morning (06:00 to 12:00) of the first postoperative day (POD) on an ascending numeric rating scale (NRS) from 0 to 10. Pairwise treatment comparisons were performed using the rank-sum test, with a p value of <0.017 indicating significance (Bonferroni adjusted). A sample size of 150 provided 80% power to detect a difference of 2.0 NRS units. RESULTS: We included 159 patients (51, 54, and 54 patients in the PNB, PAI-R, and PAI-L groups, respectively). No significant differences were found with respect to the primary end point on the morning of the first POD (median, 3.0, 4.0, and 3.0, respectively; p > 0.033 for all). Opioid consumption was low and did not differ across groups at any intervals. Median maximum pain on POD 1 was 5.0, 5.5, and 4.0, respectively, and was lower for the PAI-L group than for the PAI-R group (p = 0.006). On POD 2, maximum pain (median, 3.5, 5.0, and 3.5, respectively) was lower for the PNB group (p = 0.014) and PAI-L group (p = 0.016) compared with the PAI-R group. The PAI-L group was not significantly different from the PNB group with respect to any outcomes: postoperative opioid use including rescue intravenous opioid medication, length of stay, and hospital adverse events, and 3-month follow-up data including any complication. CONCLUSIONS: In this RCT, we found a modest improvement with respect to analgesia in patients receiving PNB compared with those receiving PAI-R, but not compared with those who had PAI-L. Secondary analyses suggested that PNB or PAI-L provides superior postoperative analgesia compared with PAI-R. For primary total hip arthroplasty, a multimodal analgesic regimen including PNB or PAI-L provides opioid-limiting analgesia. LEVEL OF EVIDENCE: Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.
引用
- Johnson RL, Amundson AW, Abdel MP, et al. Continuous Posterior Lumbar Plexus Nerve Block Versus Periarticular Injection with Ropivacaine or Liposomal Bupivacaine for Total Hip Arthroplasty: A Three-Arm Randomized Clinical Trial. J Bone Joint Surg Am. 2017. PMID: 29088038. doi:10.2106/JBJS.16.01305
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。